By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Cardioselective beta blockers > Metoprolol > Metoprolol Dosage
Cardioselective beta blockers
https://themeditary.com/dosage-information/metoprolol-dosage-8642.html

Metoprolol Dosage

Drug Detail:Metoprolol (Metoprolol [ me-toe-pro-lol ])

Drug Class: Cardioselective beta blockers

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Hypertension

METOPROLOL TARTRATE IMMEDIATE RELEASE TABLETS:
Initial dose: 100 mg orally per day in single or divided doses

Maintenance dose: 100 to 450 mg orally per day

Comments:

  • May increase dose at weekly, or longer, intervals.
  • Doses above 450 mg per day have not been studied.
  • Lower once-daily doses may not maintain full effect at the end of the 24-hour period; larger or more frequent daily doses may be required. Beta-1 selectivity diminishes as the dose is increased.

METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS:
Initial dose: 25 to 100 mg orally once a day

Maintenance dose: 100 to 400 mg orally once a day

Comments:
  • May increase dose at weekly, or longer, intervals.
  • Doses above 400 mg per day have not been studied.

Usual Adult Dose for Angina Pectoris

Initial dose:

  • Metoprolol tartrate immediate release tablets: 50 mg orally twice a day
  • Metoprolol succinate extended release tablets: 100 mg orally once a day

Maintenance dose: 100 to 400 mg per day

Comments:
  • Increase dose at weekly intervals until optimum clinical response has been obtained or pronounced slowing of heart rate occurs.
  • Doses above 400 mg per day have not been studied.

Usual Adult Dose for Myocardial Infarction

METOPROLOL TARTRATE:
Early Treatment:
Initial dose: 5 mg IV every 2 minutes as tolerated for 3 doses

  • Patients tolerant of full IV dose (15 mg): 50 mg orally every 6 hours starting 15 minutes after the last IV dose and continued for 48 hours
  • Patients intolerant of full IV dose (15 mg): 25 or 50 mg orally every 6 hours depending on the degree of intolerance starting 15 minutes after the last IV dose or as soon as their clinical condition allows

Late Treatment:
Maintenance dose: 100 mg orally twice a day

Comments:
  • Patients with contraindications to treatment during the early phase of suspected or definite myocardial infarction, patients who appear not to tolerate the full early treatment, and patients in whom the physician wishes to delay therapy for any other reason should be started on 100 mg orally twice a day as soon as their clinical condition allows.
  • Continue therapy for at least 3 months; efficacy beyond 3 months has not been conclusively established; data from studies with other beta blockers suggest a treatment duration of 1 to 3 years.

Use: Treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. Treatment with the IV formulation can be initiated as soon as the patient's clinical condition allows. Alternatively, treatment can begin within 3 to 10 days of the acute event.

Usual Adult Dose for Congestive Heart Failure

METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS:
25 mg orally once a day (12.5 mg orally once a day in patients with more severe heart failure); double dose every 2 weeks to highest tolerated dose or up to 200 mg orally once a day

Comments: Initial titration difficulty should not preclude later attempts to introduce this drug.

Use: Treatment of stable, symptomatic New York Heart Association (NYHA) Class II or III heart failure of ischemic, hypertensive, or cardiomyopathic origin.

Usual Pediatric Dose for Hypertension

METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS:
6 Years or Older:
Initial dose: 1 mg/kg orally once a day (not to exceed 50 mg orally once a day)

Maximum dose: 2 mg/kg (or 200 mg) orally once a day

Renal Dose Adjustments

No adjustment recommended

Liver Dose Adjustments

Initiate at low doses and titrate gradually according to clinical response.

Dose Adjustments

For treatment of hypertension and angina, when switching from immediate release to extended release, use the same total daily dose.

Precautions

US BOXED WARNING:

  • ISCHEMIC HEART DISEASE: Following abrupt discontinuation of therapy with beta adrenergic blockers, exacerbations of angina pectoris and myocardial infarction have occurred. When discontinuing chronically administered metoprolol, particularly in patients with ischemic heart disease, gradually reduce the dose over a period of 1 to 2 weeks and monitor the patient. If angina markedly worsens or acute coronary insufficiency develops, promptly resume therapy, at least temporarily, and take other measures appropriate for the management of unstable angina. Warn patients against interruption or discontinuation of therapy without the physician's advice. Because coronary artery disease is common and may be unrecognized, avoid abrupt discontinuation of metoprolol therapy even in patients treated only for hypertension.

Metoprolol tartrate safety and efficacy have not been established in patients younger than 18 years.
Metoprolol succinate safety and efficacy have not been established in patients younger than 6 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • If a dose is missed, the patient should take only the next scheduled dose without doubling it.
  • Administer immediate release tablets with or immediately after meals.
  • Extended release tablets are scored and can be divided; however, do not crush or chew the whole or half tablet.

Monitoring:
  • Monitor heart rate and rhythm.
  • When discontinuing a chronically administered beta blocker, reduce dose over 1 to 2 weeks and monitor carefully, especially in patients with coronary artery disease.

Patient advice:
  • Warn patients not to interrupt or discontinue therapy without a physician's advice.
  • Avoid operating automobiles and machinery or engaging in other tasks requiring alertness until the patient's response to therapy has been determined.
  • Contact the physician if difficulty in breathing occurs.
  • Inform the physician or dentist of use of this drug before any type of surgery.
  • Advise heart failure patients to consult their physician if signs or symptoms of worsening heart failure occur such as weight gain or increasing shortness of breath.

Frequently asked questions

  • What is the best time of day to take blood pressure medication?
  • Metoprolol Succinate vs Tartrate - What's the difference between them?
  • How long does Metoprolol stay in your system after you stop taking it?
  • What is Prolomet XL 50? What is the mechanism of action and what are this medicine side effects?
  • How is atenolol superior to metoprolol?
  • How long does it take for metoprolol to work?
  • Which is safer: metoprolol succinate or tartrate?
  • Is Metoprolol a blood thinner?
Share this Article
Latest News
Medical News

Gastrointestinal cancer: Can eating chicken shorten lifespan?

May 12, 2025
Shingles vaccine may lower heart disease risk by up to 8 years
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by